The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review

Patients suffering from chronic obstructive pulmonary disease (COPD) clinically manifest airway mucus hypersecretion as sputum expectoration and cough. Evidence accumulated in the past decade has shown that the cholinergic system not only regulates airway smooth muscle contraction but also the activ...

Full description

Bibliographic Details
Main Authors: Luigino Calzetta, Beatrice Ludovica Ritondo, Maria Cristina Zappa, Gian Marco Manzetti, Andrea Perduno, Janis Shute, Paola Rogliani
Format: Article
Language:English
Published: European Respiratory Society 2022-05-01
Series:European Respiratory Review
Online Access:http://err.ersjournals.com/content/31/164/210196.full
_version_ 1811225248782090240
author Luigino Calzetta
Beatrice Ludovica Ritondo
Maria Cristina Zappa
Gian Marco Manzetti
Andrea Perduno
Janis Shute
Paola Rogliani
author_facet Luigino Calzetta
Beatrice Ludovica Ritondo
Maria Cristina Zappa
Gian Marco Manzetti
Andrea Perduno
Janis Shute
Paola Rogliani
author_sort Luigino Calzetta
collection DOAJ
description Patients suffering from chronic obstructive pulmonary disease (COPD) clinically manifest airway mucus hypersecretion as sputum expectoration and cough. Evidence accumulated in the past decade has shown that the cholinergic system not only regulates airway smooth muscle contraction but also the activity of inflammatory and airway epithelial cells, including goblet cells, and submucosal gland activity. Long-acting muscarinic antagonists (LAMAs) with the most favourable M3/M2 muscarinic acetylcholine (ACh) receptors residency properties are not only excellent bronchodilators but potentially also mucus-modifying agents, able to positively impact on mucus hypersecretion and cough. The aim of this systematic review was to investigate the impact of LAMAs on mucus hypersecretion and cough in COPD patients. The evidence confirmed that LAMAs, mainly tiotropium and aclidinium, improved sputum production and cough in moderate to severe COPD. Thus, LAMAs not only antagonise the ACh-induced bronchoconstriction of the airways but also appear to limit the production of mucus secreted in response to ACh by airway goblet cells and/or submucosal glands. Further clinical studies are necessary to evaluate the impact of LAMAs exclusively on sputum symptoms and cough as primary end-points and to investigate whether LAMAs have a modulatory action on the rheological properties of mucus.
first_indexed 2024-04-12T09:03:58Z
format Article
id doaj.art-8ab3fb3f30fa4540969d1ac1860a7a0b
institution Directory Open Access Journal
issn 0905-9180
1600-0617
language English
last_indexed 2024-04-12T09:03:58Z
publishDate 2022-05-01
publisher European Respiratory Society
record_format Article
series European Respiratory Review
spelling doaj.art-8ab3fb3f30fa4540969d1ac1860a7a0b2022-12-22T03:39:09ZengEuropean Respiratory SocietyEuropean Respiratory Review0905-91801600-06172022-05-013116410.1183/16000617.0196-20210196-2021The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic reviewLuigino Calzetta0Beatrice Ludovica Ritondo1Maria Cristina Zappa2Gian Marco Manzetti3Andrea Perduno4Janis Shute5Paola Rogliani6 Dept of Medicine and Surgery, Respiratory Disease and Lung Function Unit, University of Parma, Parma, Italy Unit of Respiratory Medicine, Dept of Experimental Medicine, University of Rome “Tor Vergata”, Rome, Italy Pulmonology Dept, Sandro Pertini Hospital, Rome, Italy Unit of Respiratory Medicine, Dept of Experimental Medicine, University of Rome “Tor Vergata”, Rome, Italy Unit of Respiratory Medicine, Dept of Experimental Medicine, University of Rome “Tor Vergata”, Rome, Italy School of Pharmacy and Biomedical Science, University of Portsmouth, Portsmouth, UK Unit of Respiratory Medicine, Dept of Experimental Medicine, University of Rome “Tor Vergata”, Rome, Italy Patients suffering from chronic obstructive pulmonary disease (COPD) clinically manifest airway mucus hypersecretion as sputum expectoration and cough. Evidence accumulated in the past decade has shown that the cholinergic system not only regulates airway smooth muscle contraction but also the activity of inflammatory and airway epithelial cells, including goblet cells, and submucosal gland activity. Long-acting muscarinic antagonists (LAMAs) with the most favourable M3/M2 muscarinic acetylcholine (ACh) receptors residency properties are not only excellent bronchodilators but potentially also mucus-modifying agents, able to positively impact on mucus hypersecretion and cough. The aim of this systematic review was to investigate the impact of LAMAs on mucus hypersecretion and cough in COPD patients. The evidence confirmed that LAMAs, mainly tiotropium and aclidinium, improved sputum production and cough in moderate to severe COPD. Thus, LAMAs not only antagonise the ACh-induced bronchoconstriction of the airways but also appear to limit the production of mucus secreted in response to ACh by airway goblet cells and/or submucosal glands. Further clinical studies are necessary to evaluate the impact of LAMAs exclusively on sputum symptoms and cough as primary end-points and to investigate whether LAMAs have a modulatory action on the rheological properties of mucus.http://err.ersjournals.com/content/31/164/210196.full
spellingShingle Luigino Calzetta
Beatrice Ludovica Ritondo
Maria Cristina Zappa
Gian Marco Manzetti
Andrea Perduno
Janis Shute
Paola Rogliani
The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review
European Respiratory Review
title The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review
title_full The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review
title_fullStr The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review
title_full_unstemmed The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review
title_short The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review
title_sort impact of long acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease a systematic review
url http://err.ersjournals.com/content/31/164/210196.full
work_keys_str_mv AT luiginocalzetta theimpactoflongactingmuscarinicantagonistsonmucushypersecretionandcoughinchronicobstructivepulmonarydiseaseasystematicreview
AT beatriceludovicaritondo theimpactoflongactingmuscarinicantagonistsonmucushypersecretionandcoughinchronicobstructivepulmonarydiseaseasystematicreview
AT mariacristinazappa theimpactoflongactingmuscarinicantagonistsonmucushypersecretionandcoughinchronicobstructivepulmonarydiseaseasystematicreview
AT gianmarcomanzetti theimpactoflongactingmuscarinicantagonistsonmucushypersecretionandcoughinchronicobstructivepulmonarydiseaseasystematicreview
AT andreaperduno theimpactoflongactingmuscarinicantagonistsonmucushypersecretionandcoughinchronicobstructivepulmonarydiseaseasystematicreview
AT janisshute theimpactoflongactingmuscarinicantagonistsonmucushypersecretionandcoughinchronicobstructivepulmonarydiseaseasystematicreview
AT paolarogliani theimpactoflongactingmuscarinicantagonistsonmucushypersecretionandcoughinchronicobstructivepulmonarydiseaseasystematicreview
AT luiginocalzetta impactoflongactingmuscarinicantagonistsonmucushypersecretionandcoughinchronicobstructivepulmonarydiseaseasystematicreview
AT beatriceludovicaritondo impactoflongactingmuscarinicantagonistsonmucushypersecretionandcoughinchronicobstructivepulmonarydiseaseasystematicreview
AT mariacristinazappa impactoflongactingmuscarinicantagonistsonmucushypersecretionandcoughinchronicobstructivepulmonarydiseaseasystematicreview
AT gianmarcomanzetti impactoflongactingmuscarinicantagonistsonmucushypersecretionandcoughinchronicobstructivepulmonarydiseaseasystematicreview
AT andreaperduno impactoflongactingmuscarinicantagonistsonmucushypersecretionandcoughinchronicobstructivepulmonarydiseaseasystematicreview
AT janisshute impactoflongactingmuscarinicantagonistsonmucushypersecretionandcoughinchronicobstructivepulmonarydiseaseasystematicreview
AT paolarogliani impactoflongactingmuscarinicantagonistsonmucushypersecretionandcoughinchronicobstructivepulmonarydiseaseasystematicreview